OR WAIT null SECS
July 03, 2024
A greater number of patients with Duchenne muscular dystrophy will be able to be treated after FDA's approval of a gene therapy.
June 04, 2024
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.
Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.
May 30, 2024
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 25, 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
May 09, 2024
The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy.
A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of biologics.
May 03, 2024
Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.
April 03, 2024
Packaging and packaging line innovations are addressing the industry’s growing use of biologics.